journal article·2023-09-11

Effect of Structural Elements of Heparin-Mimicking Polymers on Vascular Cell Distribution and Functions: Chemically Homogeneous or Heterogeneous?

Jiao Lei, Wei Sun, Denghai Sheng, Sujian Wang, Xiaoli Liu, Tingting Zhao, Hong Chen

Publisher page

Abstract

Heparin-mimicking polymers (HMPs) are artificially synthesized alternatives to heparin with comparable regulatory effects on protein adsorption and cell behavior. By introducing two major structural elements of HMPs (sulfonate- and glyco-containing units) to different areas of material surfaces, heterogeneous surfaces patterned with different HMPs and homogeneous surfaces patterned with the same HMPs can be obtained. In this work, heterogeneous HMP-patterned poly(dimethylsiloxane) (PDMS) surfaces with sulfonate-containing polySS (pS) and glyco-containing polyMAG (pM) distributed in circular patterns (with a diameter of 300 μm) were prepared (S–M and M–S). Specifically, pS and pM were distributed inside and outside the circles on S–M, respectively, and exchanged their distribution on M–S. Homogeneous HMP-patterned silicone surfaces (SM–SM) where sulfonate- and glyco-containing poly(SS- co -MAG) (pSM) were distributed uniformly were prepared. Vascular cells showed interestingly different behaviors between chemically homogeneous and heterogeneous surfaces. They tended to grow in the sulfonate-modified area on S–M and M–S and were distributed uniformly on SM–SM. Compared with M–S, S–M showed a better promoting effect on the growth of vascular cells. Among all the samples, SM–SM exhibited the highest proliferation density and an optimum spreading state of vascular cells, as well as the highest human umbilical vein endothelial cell (HUVEC) viability (∼99%) and relatively low human umbilical vein smooth muscle cell (HUVSMC) viability (∼72%). By heterogeneous or homogeneous patterning with different structural elements of HMPs, the modified silicone surfaces spatially guided vascular cell distribution and functions. This strategy provides a new surface engineering approach to the study of cell–HMP interactions.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Cardiac Valve Diseases and Treatments · Proteoglycans and glycosaminoglycans research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State and Local Joint Engineering Laboratory for Novel Functional Polymeric Materials, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, 199 Ren-Ai Road, Suzhou 215123, P.R. China

Jiangsu Biosurf Biotech Company Ltd., Building 26, Dongjing Industrial Square, No. 1, Jintian Road, Suzhou Industrial Park, Suzhou 215123, P.R. China

Funding

National Natural Science Foundation of China · Priority Academic Program Development of Jiangsu Higher Education Institutions · Collaborative Innovation Center of Soochow University and Biosurf · cooperation project ?development of surface modification techniques? · Jiangsu Province Industry-University-Research Cooperation Project

References (38)

Show source-provided references
1. 10.1002/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.CO;2-B10.1002/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.CO;2-B ↗
2. 10.1128/mcb.12.1.240-247.199210.1128/mcb.12.1.240-247.1992 ↗
3. 10.1016/j.actbio.2014.12.01410.1016/j.actbio.2014.12.014 ↗
4. 10.1002/pi.422910.1002/pi.4229 ↗
5. 10.1021/acsbiomaterials.3c0001710.1021/acsbiomaterials.3c00017 ↗
6. 10.1021/acsbiomaterials.2c0049210.1021/acsbiomaterials.2c00492 ↗
7. 10.1021/acs.biomac.6b0114710.1021/acs.biomac.6b01147 ↗
8. 10.1016/j.biomaterials.2012.07.06610.1016/j.biomaterials.2012.07.066 ↗
9. 10.1007/s00424-007-0212-810.1007/s00424-007-0212-8 ↗
10. 10.1016/j.colsurfb.2022.11233710.1016/j.colsurfb.2022.112337 ↗
11. 10.1016/j.colsurfb.2018.03.04710.1016/j.colsurfb.2018.03.047 ↗
12. 10.1021/acsbiomaterials.2c0061610.1021/acsbiomaterials.2c00616 ↗
13. 10.1155/2013/92831510.1155/2013/928315 ↗
14. 10.1002/adma.20220046410.1002/adma.202200464 ↗
15. 10.1021/am502692k10.1021/am502692k ↗
16. 10.1021/acsami.7b1672310.1021/acsami.7b16723 ↗
17. 10.1039/D0TB01000F10.1039/D0TB01000F ↗
18. 10.1016/j.jcis.2021.06.10010.1016/j.jcis.2021.06.100 ↗
19. 10.1007/s10853-011-5634-110.1007/s10853-011-5634-1 ↗
20. 10.1039/C9FD00015A10.1039/C9FD00015A ↗
21. 10.1039/C8TB01441H10.1039/C8TB01441H ↗
22. 10.1039/c6tb00606j10.1039/c6tb00606j ↗
23. 10.1021/am100196z10.1021/am100196z ↗
24. 10.1039/C4TB01600A10.1039/C4TB01600A ↗
25. 10.1007/s10439-008-9467-210.1007/s10439-008-9467-2 ↗
26. 10.1016/j.actbio.2004.08.00310.1016/j.actbio.2004.08.003 ↗
27. 10.1016/j.lungcan.2005.09.00510.1016/j.lungcan.2005.09.005 ↗
28. 10.1021/ja803676r10.1021/ja803676r ↗
29. 10.1126/sciadv.abd821710.1126/sciadv.abd8217 ↗
30. 10.1021/bm501882b10.1021/bm501882b ↗
31. 10.1074/jbc.271.10.551910.1074/jbc.271.10.5519 ↗
32. 10.1016/j.bone.2021.11603410.1016/j.bone.2021.116034 ↗
33. 10.1074/jbc.273.46.3033610.1074/jbc.273.46.30336 ↗
34. 10.1039/c9tb02796c10.1039/c9tb02796c ↗
35. 10.1002/admi.20190000810.1002/admi.201900008 ↗
36. 10.1016/0142-9612(91)90191-C10.1016/0142-9612(91)90191-C ↗
37. 10.1016/j.msec.2020.11100710.1016/j.msec.2020.111007 ↗
38. 10.1002/jbm.a.3652110.1002/jbm.a.36521 ↗